Journal of Clinical Oncology Issues Research Articles in Oct. 1, 2021 Edition
September 29, 2021
September 29, 2021
ALEXANDRIA, Virginia, Sept. 29 -- The Journal of Clinical Oncology, a journal from the American Society of Clinical Oncology that says it disseminates clinical oncology research, published research articles on the following topics in its Oct. 1, 2021 edition:
RAPID COMMUNICATIONS:
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
ORIGINAL REP . . .
RAPID COMMUNICATIONS:
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
ORIGINAL REP . . .
